Submitted by: Submitted by davidbrownamr
Views: 10
Words: 433
Pages: 2
Category: Business and Industry
Date Submitted: 11/23/2015 01:25 AM
Global Depression Therapy & Treatment Market Forecast 2014 - 2021
AcuteMarketReports.com has announced the addition of " Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders, SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis, Physical Therapy Market, Forecast 2014 – 2021 " Market Research Report to their Database.
Depression treatment market is segmented on the basis of antidepressants drugs, devices and therapies. Antidepressants are the largest market segment. Antidepressants are the most popular treatment methods. Every year more than five billion prescriptions are written globally. Antidepressants segment consists of big pharmaceuticals companies like Eli Lily, Pfizer, GlaxoSmithKline and Forest Laboratories.
View Full Report with TOC @ http://www.acutemarketreports.com/report/global-depression-therapy-treatment-market
All these companies are branded drug manufacturers. Some of the popular drugs produced by these companies are Cymbalta (Eli Lily) and Effexor and Pristiq (Pfizer). The devices market is the fastest growing market segment.
1. Pfizer
2. GlaxoSmithKline
3. Forest Laboratories
4. Abbot Laboratories
5. Eli Lilly and Company
6. Merck Sharp &Dohme
7. Sanofi
8. Teva Pharmaceuticals Industries
9. Mayo Clinic...
Request a sample of Report @ http://www.acutemarketreports.com/request-free-sample/48532
List of Tables:
TABLE 1 Global Depression Drugs and Devices Market 2013- 2021 (In $million)
TABLE 2 Timeline of the branded drug expiration/Launch in the U.S.
TABLE 3 R& D spending by pharmaceutical giants in 2013
TABLE 4 Global antidepressants drug market, 2013-2021 (in $million)
TABLE 5 Price of Flouoxetine in different drug store in 2012
TABLE 6 Price of Paroxetine (Paxil), North America
TABLE 7 Global Sertaline drug market, 2013-2021, (in $million)......